A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Clinical trial NCT05440344 · COMPLETED

Trial details

NCT number: NCT05440344
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Insufficiency Healthy

Start date: 2022-07-05
Primary completion: 2024-02-28
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.